Sign In

Login

Password

Forgot Password ? Sign Up

MTOR (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "MTOR" in German language version.

Last modified:

Ref.Un. Ref.Website
Global rank German rank
55nih.gov
5th place
7th place
22doi.org
2nd place
3rd place
22aerzteblatt.de
3,794th place
234th place
22nejm.org
2,717th place
2,224th place
11zdb-katalog.de
107th place
5th place
11jci.org
low place
low place
11genesdev.org
low place
low place
11physiology.org
6,780th place
8,736th place
11landesbioscience.com
low place
low place

aerzteblatt.de (Global: 3,794th place; German: 234th place)

  • G. Blaeser-Kiel: Sirolimus zum Transplantatschutz. Bessere Langzeitprognose durch geringere Tumorinzidenz. In: Deutsches Ärzteblatt. Nr. 104, 2007, S. A-1255 (Artikel).
  • W. Kühn, G. Walz: Autosomal dominante polyzystische Nierenerkrankung. In: Dtsch Arztebl. Band 104, Nr. 44, 2007, S. 3022–3028 (Artikel).

doi.org (Global: 2nd place; German: 3rd place)

genesdev.org (Global: low place; German: low place)

  • N. Hay, N. Sonenberg: Upstream and downstream of mTOR. In: Genes Dev. Nr. 18, 2004, S. 1926–1945 (Artikel). PMID 15314020

jci.org (Global: low place; German: low place)

  • Ushma S. Neill: A conversation with Michael Hall. In: Journal of Clinical Investigation. Band 127, Nr. 11, 1. November 2017, ISSN 0021-9738, S. 3916–3917, doi:10.1172/JCI97760 (jci.org [abgerufen am 23. Mai 2023]).

landesbioscience.com (Global: low place; German: low place)

  • Janet E. Dancey: MTOR and Related Pathways. In: Cancer Biology & Therapy. Nr. 5, 2006, S. 1065–1073 (PDF).

nejm.org (Global: 2,717th place; German: 2,224th place)

content.nejm.org

  • Henrik Ekberg et al.: Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. In: N Engl J Med. Nr. 357, 2007, S. 2561–2575 (Abstract).
  • John J. Bissler et al.: Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis. In: N Engl J Med. Nr. 358, 2008, S. 140–151 (Abstract).

nih.gov (Global: 5th place; German: 7th place)

ncbi.nlm.nih.gov

  • J. Heitman, N. R. Movva, M. N. Hall: Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. In: Science. Nr. 253, 1991, S. 905–909, PMID 1715094.
  • N. Hay, N. Sonenberg: Upstream and downstream of mTOR. In: Genes Dev. Nr. 18, 2004, S. 1926–1945 (Artikel). PMID 15314020
  • R. Loewith et al.: Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control. In: Molecular Cell. Band 10, Nr. 3, 2002, S. 457–468, PMID 12408816.
  • Gary Hudes et al.: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. In: N Engl J Med. Nr. 356, 2007, S. 2271–2281, PMID 17538086.
  • Wilfred Lieberthal, Jerrold S Levine: The role of the mammalian target of rapamycin (mTOR) in renal disease. In: Journal of the American Society of Nephrology. Band 20, Nr. 12, Dezember 2009, S. 2493–2502, doi:10.1681/ASN.2008111186, PMID 19875810.

physiology.org (Global: 6,780th place; German: 8,736th place)

physiologyonline.physiology.org

  • Xuemin Wang, Christopher G. Proud: The mTOR Pathway in the Control of Protein Synthesis. In: Physiology. Nr. 21, 2006, S. 362–369 (Artikel).

zdb-katalog.de (Global: 107th place; German: 5th place)

  • Ushma S. Neill: A conversation with Michael Hall. In: Journal of Clinical Investigation. Band 127, Nr. 11, 1. November 2017, ISSN 0021-9738, S. 3916–3917, doi:10.1172/JCI97760 (jci.org [abgerufen am 23. Mai 2023]).